An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))

NCT00568178 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Proteinuria

Interventions

DRUG: Losartan Potassium
OTHER: Comparator: Placebo (Losartan)
DRUG: Comparator: amlodipine besylate
OTHER: Comparator: Placebo (amlodipine besylate)
OTHER: Placebo (Losartan)
DRUG: Enalapril Maleate

Sponsor

Organon and Co